<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0420</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Urug.Cardiol.]]></abbrev-journal-title>
<issn>1688-0420</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Cardiología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-04202018000300131</article-id>
<article-id pub-id-type="doi">10.29277/cardio.33.3.10</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Lo mejor del Congreso 2018 de la Sociedad Europea de Cardiología]]></article-title>
<article-title xml:lang="en"><![CDATA[The best of the 2018 European Society of Cardiology Congress]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ache]]></surname>
<given-names><![CDATA[Yamel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bonino]]></surname>
<given-names><![CDATA[Agustina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guamán]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lorenzo]]></surname>
<given-names><![CDATA[Sebastián]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Noria]]></surname>
<given-names><![CDATA[Sofía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Consejo Editorial de la Revista Uruguaya de Cardiología  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>33</volume>
<numero>3</numero>
<fpage>131</fpage>
<lpage>149</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-04202018000300131&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-04202018000300131&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-04202018000300131&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: El Congreso Europeo de Cardiología se llevó a cabo en la ciudad de Múnich del 25 al 29 de agosto. Sin duda, uno de los eventos más importantes e innovadores de la comunidad cardiológica reunió a más de 32.000 profesionales, con destacados invitados internacionales y múltiples actividades científicas. Además de las tradicionales presentaciones de estudios, se inauguró un área de Salud Digital: Digital Health Area donde se llevaron a cabo sesiones continuas sobre E-Cardiology, con múltiples presentaciones de apps móviles, telemedicina y tecnología digital tanto para los profesionales como para la comunidad. Se presentaron las nuevas guías europeas sobre Hipertensión Arterial, tan esperadas luego del debate planteado en relación con las guías americanas en 2017. Las pautas europeas se mantendrán dentro del umbral de diagnóstico de 140/90 mmHg y se centrarán en mejorar las tasas de control a través de combinaciones iniciales de dos fármacos antihipertensivos para la mayoría de los pacientes. Realizaremos un breve resumen de algunos de los principales trabajos científicos presentados: - Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease: ARRIVE. - Coronary CT Angiography and 5-Year Risk of Myocardial Infarction: The SCOT-HEART Investigators. - Partial Oral Treatment of Endocarditis: POET. - Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: GLOBAL LEADERS. - One-Year Outcomes after PCI Strategies in Cardiogenic Shock: CULPRIT-SHOCK.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary: The European Congress of Cardiology was held at Munich from August 25th to 29th. Undoubtedly one of the most important and innovative events of the cardiology community, it brought together more than 32.000 professionals, with prominent international guests and multiple scientific activities. In addition to the traditional presentations of studies, ESC 2018 inaugurated a: Digital Health Area, where continuous sessions on E-Cardiology were held with multiple presentations of mobile apps, telemedicine and digital technology for both, the professionals and the community. The new european guidelines on Arterial Hypertension, awaited after the discussion related with the American guidelines in 2017, were presented. European blood pressure guidelines will stick with the 140/90 mmHg diagnostic threshold and will focus on improving control rates through initial two-drug antihypertensive combinations for most patients. We will make a brief summary of some of the main scientific trials presented: - Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease: ARRIVE. - Coronary CT Angiography and 5-Year Risk of Myocardial Infarction: The SCOT-HEART Investigators. - Partial Oral Treatment of Endocarditis: POET. - Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: GLOBAL LEADERS. - One-Year Outcomes after PCI Strategies in Cardiogenic Shock: CULPRIT-SHOCK]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Prevención primaria]]></kwd>
<kwd lng="es"><![CDATA[Angiografía coronaria]]></kwd>
<kwd lng="es"><![CDATA[Angiografía por tomografía computarizada]]></kwd>
<kwd lng="es"><![CDATA[Infarto]]></kwd>
<kwd lng="es"><![CDATA[Endocarditis]]></kwd>
<kwd lng="es"><![CDATA[Stents liberadores de fármacos]]></kwd>
<kwd lng="es"><![CDATA[Shock cardiogénico]]></kwd>
<kwd lng="en"><![CDATA[Primary prevention]]></kwd>
<kwd lng="en"><![CDATA[Coronary Angiography]]></kwd>
<kwd lng="en"><![CDATA[Computed Tomography Angiography]]></kwd>
<kwd lng="en"><![CDATA[Infarction]]></kwd>
<kwd lng="en"><![CDATA[Endocarditis]]></kwd>
<kwd lng="en"><![CDATA[Drug- Eluting Stents]]></kwd>
<kwd lng="en"><![CDATA[Cardiogenic]]></kwd>
<kwd lng="en"><![CDATA[Shock]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaziano]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Brotons]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Coppolecchia]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cricelli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Darius]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Gorelick]]></surname>
<given-names><![CDATA[PB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of aspirin to reduce risk of initial vascular events in patients at moderate risk cardiovascular disease (ARRIVE): a randomised double-blind, placebo-controlled trial]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2018</year>
<volume>392</volume>
<numero>10152</numero>
<issue>10152</issue>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Highlights del Congreso Europeo de Cardiología</collab>
<source><![CDATA[]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Munich ]]></publisher-loc>
<publisher-name><![CDATA[IntraMed]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Newby]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Adamson]]></surname>
<given-names><![CDATA[PD]]></given-names>
</name>
<name>
<surname><![CDATA[Berry]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Boon]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Dweck]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Flather]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Coronary CT angiography and 5-year risk of myocardial infarction]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2018</year>
<volume>379</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>924-33</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davenport]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[SCOT-HEART: La angiotomografía computarizada coronaria se vinculó a menos muertes e infarto de miocardio no mortal, en el dolor torácico estable]]></source>
<year>2018</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Medscape]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iversen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ihlemann]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Gill]]></surname>
<given-names><![CDATA[SU]]></given-names>
</name>
<name>
<surname><![CDATA[Madsen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Elming]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Jenden]]></surname>
<given-names><![CDATA[KT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Partial oral versus intravenous antibiotic treatment of endocarditis]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baddour]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[WR]]></given-names>
</name>
<name>
<surname><![CDATA[Bayer]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Infective endocarditis in adults diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2015</year>
<volume>132</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>1435-86</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Habib]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lancellotti]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Antunes]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bongiorni]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Casalta]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Del Zotti]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2015 ESC guidelines for the management of infective endocarditis the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2015</year>
<volume>36</volume>
<numero>44</numero>
<issue>44</issue>
<page-range>3075-128</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dworkin]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Sande]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Chambers]]></surname>
<given-names><![CDATA[HF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1989</year>
<volume>2</volume>
<page-range>1071-3</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iversen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Høst]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Bruun]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
<name>
<surname><![CDATA[Elming]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Pump]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Christensen]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Partial oral treatment of endocarditis]]></article-title>
<source><![CDATA[Am Heart J]]></source>
<year>2013</year>
<volume>165</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>116-22</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wendling]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Switch to oral antibiotics Safe in left-sided endocarditis, Slashes LOS]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Munich ]]></publisher-loc>
<publisher-name><![CDATA[Medscape]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vranckx]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Valgimigli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jüni]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Hamm]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Steg]]></surname>
<given-names><![CDATA[PG]]></given-names>
</name>
<name>
<surname><![CDATA[Heg]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent a multicentre, open-label, randomised superiority trial]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2018</year>
<volume>392</volume>
<numero>10151</numero>
<issue>10151</issue>
<page-range>31858-0</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Lo mejor de ESC 2018: estudio GLOBAL LEADERS]]></article-title>
<source><![CDATA[Revista Española de Cardiología]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Global Leaders]]></surname>
</name>
</person-group>
<source><![CDATA[]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Rotterdam ]]></publisher-loc>
<publisher-name><![CDATA[European Cardiovascular Research Institute]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<source><![CDATA[Global Leaders trial: Long-term ticagrelor monotherapy after stenting does not improve outcomes vs standard dual antiplatelet therapy. ESC Congress news 2018 - Munich, Germany (Internet)]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Sophia Antipolis Cedex ]]></publisher-loc>
<publisher-name><![CDATA[ESC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[GLOBAL LEADERS: un mes de aspirina y 24 meses de ticagrelor como estrategia para pacientes con angioplastia coronaria]]></article-title>
<source><![CDATA[Sociedad Interamericana de Cardiología]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<source><![CDATA[ESC 2018 GLOBAL LEADERS: el ticagrelor como monoterapia no supera a los esquemas clásicos post angioplastia (Internet)]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[SOLACI]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<collab>O'Riordan M</collab>
<source><![CDATA[GLOBAL LEADERS: ticagrelor monotherapy fails to beat conventional DAPT After PCI (Internet)]]></source>
<year>2018</year>
<publisher-loc><![CDATA[TCTMD ]]></publisher-loc>
<publisher-name><![CDATA[The Heart Beat]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bhatt]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin-still the GLOBAL LEADER in antiplatelet therapy]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2018</year>
<volume>392</volume>
<numero>10151</numero>
<issue>10151</issue>
<page-range>896-7</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ibanez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Agewall]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Antunes]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bucciarelli-Ducci]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bueno]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2018</year>
<volume>39</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>119-77</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bajraktari]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Jashari]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ibrahimi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Alfonso]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Jashari]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ndrepepa]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Complete revascularization for patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease a meta-analysis of randomized trials]]></article-title>
<source><![CDATA[Coron Artery Dis]]></source>
<year>2018</year>
<volume>29</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>204-15</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thiele]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Akin]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sandri]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fuernau]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[de Waha]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Meyer-Saraei]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PCI strategies in patients with acute myocardial infarction and cardiogenic shock]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2017</year>
<volume>377</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>2419-32</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Neumann F-J]]></surname>
</name>
<name>
<surname><![CDATA[Sousa-Uva]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ahlsson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alfonso]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Banning]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Benedetto]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2018 ESC/EACTS Guidelines on myocardial revascularization]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2018</year>
<volume>00</volume>
<page-range>1-96</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thiele]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Akin]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sandri]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[de Waha-Thiele]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Meyer-Saraei]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Fuernau]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[One-Year Outcomes after PCI Strategies in Cardiogenic Shock]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wendling]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[CULPRIT-SHOCK: benefits remain at 1 year for culprit-lesion-only PCI in MI with shock (consulta: 3 Set 2018)]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Munich ]]></publisher-loc>
<publisher-name><![CDATA[Medscape]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
